Answers are grounded in this paper and cite their sources.
Kantorov A, Soukup V, apoun O. Cirkulujc ndorov buky v onkourologii. V onkourologii vyuvme adu biomarker v diagnostice, monitoraci lby, pedpovdi relapsu i rezistence na terapii. Nejastji uvanm biomarkerem v onkourologii je prostatick specifick antigen (PSA) u lby karcinomu prostaty. Dal markery se uplatuj u ndor varlat, konkrtn alfa‑fetoprotein (AFP), beta‑podjednotka lidskho choriogonadotropinu (beta‑hCG) a lakttdehydrogenza (LD). U karcinomu moovho mche vyuvme vyeten cytologie moi, jejm skalm je vak i pes dobrou senzitivitu a specificitu v zchytu high‑grade urotelilnho karcinomu nzk senzitivita pi detekci low‑grade lz. U ostatnch onkourologickch onemocnn nm vak stle specifick biomarkery chyb. V souasn dob probh vzkum cirkulujcch ndorovch bunk (circulating tumor cells - CTC), kter jsou odebrny pomoc tzv. "tekut biopsie" a mohly by se stt slibnmi biomarkery v ad onemocnn. V tto prci podvme pehled aktulnho vyuit CTC u onkourologickch onemocnn.
No takes yet. Share an insight, caveat, or question.
Kantorová et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: